Patents by Inventor Amit RAYCHOUDHURI

Amit RAYCHOUDHURI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADAPTATION OF ENTEROVIRUS TO VERO CELLS AND VACCINE FORMULATIONS THEREOF
    Publication number: 20220160862
    Abstract: Provided is an Enterovirus D68 adapted to propagate to high titers in Vero cells and method of adaptation thereof. Also provided is a suitable vaccine composition including inactivated Enterovirus D68 antigen.
    Type: Application
    Filed: December 27, 2019
    Publication date: May 26, 2022
    Inventors: Amit Raychoudhuri, Krishna Murthy Ella
  • Synthetic polypeptide epitope based vaccine composition
    Patent number: 11273215
    Abstract: Conserved epitopes selected from EV71 and CVA16, the two major causative agents of Hand Foot and Mouth Disease has been used to develop sub-unit bivalent vaccine antigen construct. The said vaccine described in this invention is capable to provide cross-protection to diverse EV71 and CVA16 infection causing strains. Further disclosed are the expression of the multi-epitope vaccine antigen coding gene and the purification process involved thereof. This present invention also discloses vaccine formulations against Hand Foot and Mouth Disease and other enterovirus infections comprising the recombinant vaccine antigen construct of the present invention.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: March 15, 2022
    Assignee: BHARAT BIOTECH INTERNATIONAL LIMITED
    Inventor: Amit Raychoudhuri
  • A SYNTHETIC POLYPEPTIDE EPITOPE BASED VACCINE COMPOSITION
    Publication number: 20210220466
    Abstract: Conserved epitopes selected from EV71 and CVA16, the two major causative agents of Hand Foot and Mouth Disease has been used to develop sub-unit bivalent vaccine antigen construct. The said vaccine described in this invention is capable to provide cross-protection to diverse EV71 and CVA16 infection causing strains. Further disclosed are the expression of the multi-epitope vaccine antigen coding gene and the purification process involved thereof. This present invention also discloses vaccine formulations against Hand Foot and Mouth Disease and other enterovirus infections comprising the recombinant vaccine antigen construct of the present invention.
    Type: Application
    Filed: July 3, 2018
    Publication date: July 22, 2021
    Applicant: BHARAT BIOTECH INTERNATIONAL LIMITED
    Inventor: Amit RAYCHOUDHURI